Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Thyroid Neoplasms × lenvatinib × Clear all

Phase

Status

Completed 6 Recruiting 2 Approved for marketing 2 Unknown 1 Terminated 1 Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Liver Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1

Interventions

lenvatinib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03139747 2021-10-15

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

Thomas Jefferson University

Phase 2 Suspended

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡